mochi glp 1 Exciting Beginnings at GLP1 with Health Let's clarify a few things

The FDA has issued more than 85 warning letters to telehealth companies since September 2025 over misleading marketing claims, making it harder to know which providers operate with proper compliance

Christopher K Rayner, Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia

GLP-1 drugs are at the center of this transition, acting as a bridge between traditional metabolic care and newer, more patient-driven models

Its actions on GIP receptors is what gives it an edge over other injection therapies like semaglutide (Wegovy)

Unlike oral capsules or injectables, these adhesive patches are applied directly to the skin, allowing ingredients to absorb gradually into the bloodstream over several hours